FDA Import Refusal 799-2500089-7/10003/1 — London Drug 16

London Drug 16 — FEI 3003891536

The FDA refused shipment 799-2500089-7/10003/1 from London Drug 16 (Canada) on Oct 28, 2025. The refused product falls under Drugs and Biologics — INSULIN LISPRO PROTAMINE (ANTI-DIABETIC). Cited charge: 75

Refusal details

Date
Oct 28, 2025
Country
Canada
Product Category
Drugs and Biologics
Product Code
61PCY58 INSULIN LISPRO PROTAMINE (ANTI-DIABETIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.